Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Millenium cement restrictor:

This article was originally published in Clinica

Executive Summary

Millenium Biologix has received US FDA 510(k) clearance to market its Microporous Skelite resorbable cement restrictor for use in orthopaedic surgeries such as those involving the femoral and tibial canals in hip stem and total knee replacements. The implant is the first device based on the firm's Microporous Skelite technology to reach the market; the technology enables the development of specialised synthetic bone graft implants with greater compressive strength and impact resistance, claims the Kingston, Ontario firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058152

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel